14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
AIFU vs BON: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Bon Natural Life Limited Class A (BON) is the stronger overall head-to-head candidate over AIFU Inc. Class A Ordinary Share (AIFU) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AIFU carries a Unified Composite Score of 58.5/100 (HOLD) at $9.76 (18.8x Forward P/E, -220.0% operating margin), whereas BON carries 52.3/100 (HOLD) at $1.02 (2.4x Forward P/E, -45.5% operating margin).
Composite vs. Pillar Nuance: While AIFU currently prints a higher short-term Unified Composite Score (58.5/100 HOLD vs. BON 52.3/100 HOLD), BON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-45.5% vs. -220.0% operating margin) and revenue trajectory (+1.9% vs. -24.0% YoY).
Technical & Structure Timing Caution: AIFU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.1); meanwhile BON is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AIFU vs BON. Trailing 12-month operating profitability (AIFU -220.0% vs BON -45.5%) and valuation multiples (AIFU 18.8x vs BON 2.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Specialty Chemicals value chain with $9.0M market capitalization and -45.5% operating margin.
OpEx & R&D Reinvestment67.6% of Rev ($13M)
90D Engineering Disclosures0 Published
Investor FAQ AIFU vs BON Key Questions & Quantitative Answers
As of Nov 17, 2026, Bon Natural Life Limited Class A (BON) is the stronger overall head-to-head candidate over AIFU Inc. Class A Ordinary Share (AIFU) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AIFU carries a Unified Composite Score of 58.5/100 (HOLD) at $9.76 (18.8x Forward P/E, -220.0% operating margin), whereas BON carries 52.3/100 (HOLD) at $1.02 (2.4x Forward P/E, -45.5% operating margin). Composite vs. Pillar Nuance: While AIFU currently prints a higher short-term Unified Composite Score (58.5/100 HOLD vs. BON 52.3/100 HOLD), BON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-45.5% vs. -220.0% operating margin) and revenue trajectory (+1.9% vs. -24.0% YoY). Technical & Structure Timing Caution: AIFU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.1); meanwhile BON is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BON leads the Growth & Scale pillar: AIFU posts -24.0% YoY revenue growth and -96.8% YoY earnings growth on $485M TTM revenue (50.9% gross margin, -220.0% operating margin), compared with BON at +1.9% YoY revenue growth and -41.0% YoY earnings growth on $19M TTM revenue (22.1% gross margin, -45.5% operating margin). On trailing 12-month operating scale, AIFU generates $485M in USD-normalized revenue versus $19M for BON. In operating R&D and SG&A reinvestment, AIFU deploys N/A (0 90-day corporate R&D disclosures) versus 67.6% of Rev ($13M) (0 disclosures) for BON.
BON screens cheaper on headline valuation multiples. AIFU trades at 18.8x Forward P/E, 20.4x Trailing P/E, N/M PEG, and 1.2x EV/Revenue (unreported EBITDA margin), whereas BON trades at 2.4x Forward P/E, 2.4x Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-38.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AIFU (-112.3% ROE) versus BON (-21.8% ROE) capital efficiency.
In options market volatility and institutional positioning, AIFU carries 142.0% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-7.07β · 88% Vol realized risk). By comparison, BON carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.06β · 35% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.